{
    "nct_id": "NCT04162015",
    "official_title": "Feasibility and Safety of Neoadjuvant Nivolumab and Chemotherapy for Resectable Malignant Pleural Mesothelioma",
    "inclusion_criteria": "* Age ≥ 18 years\n* Karnofsky performance status > 70%\n* Pathologic diagnosis of malignant pleural mesothelioma.\n* Potentially resectable by pleurectomy/decortication, as assessed by thoracic surgeon\n* Negative serum pregnancy test in women of childbearing potential\n* Female patients of childbearing potential must agree to use a highly effective form of contraception for the duration of the study and for at least 5 months after the last administration of nivolumab and at least 6 months after last administration of pemetrexed, whichever is longer\n* Male patients with female partners of childbearing potential must agree to use a highly effective form of contraception for the duration of the study and for at least 7 months after the last administration of nivolumab and at least 3 months after the last administration of pemetrexed, whichever is longer\n* Adequate archival or fresh tissue for correlative analysis. Archival tissue will be deemed acceptable as long as their was no interval therapy prior to cycle 1 day 1 of protocol therapy. If sufficient archival or fresh tissue is not available, then a repeat biopsy at baseline prior to starting study treatment will be required as long as medically safe and feasible\n* Absolute neutrophil count ≥ 1000/mcL\n* Total bilirubin ≤ 1.5 mg/dl\n* AST and ALT ≤ 3.0 x upper limit of normal\n* Creatinine ≤ 1.5 x upper limit of normal\n* Negative HIV serology blood test\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Prior treatment with chemotherapy or immunotherapy for mesothelioma\n* Autoimmune disease requiring systemic immune modulating treatment during the past two years\n* Pregnant or lactating women\n* Known active hepatitis B or hepatitis C\n* Current use of systemic prednisone at dose ≥ 10 mg daily (or the equivalent dose with another corticosteroid)\n* Serious concurrent medical illness or another active cancer requiring treatment\n* Active pneumonitis",
    "miscellaneous_criteria": ""
}